In vitro and in vivo studies suggest that liver fat-storing cells (FSC) may play an important role in the development of liver fibrosis. We explored the effects of platelet-derived growth factor (PDGF), epidermal growth factor (EGF), transforming growth factor (TGF)-alpha and TGF-beta, and basic fibroblast growth factor (bFGF) on DNA synthesis and growth of rat liver FSC. PDGF, EGF, TGF-alpha, and bFGF induced a dose-dependent increase in DNA synthesis with a peak effect at 24 h. PDGF produced the most striking effect with a maximum 18-fold increase over control. EGF, TGF-alpha, and bFGF elicited a maximum three-to fourfold increase in DNA synthesis. Analysis of growth curves revealed a similar pattern of potency of the growth factors. TGF-beta did not affect DNA synthesis of FSC; however, TGF-beta markedly potentiated the stimulatory effects of both EGF and PDGF. FSC showed high specific binding of '25I-PDGF and Scatchard analysis revealed high affinity receptors with an apparent Kd of 2.3 X 10-10 M. Our data suggest that PDGF is a key mitogen for FSC and that the coordinate release of other growth factors together with PDGF by inflammatory cells represents a potent potential stimulus for FSC proliferation in conditions of chronic self-perpetuating liver inflammation.
and in the production of several matrix components. FSC isolated from rat liver and maintained in culture have been shown to secrete collagen (mainly types I and III; 2-4), laminin (5) , proteoglycans (6) , and fibronectin (2, 7) . Actually, FSC represent the main source of collagen in primary hepatocyte cultures (8) and in vivo studies have also supported a role in fibrogenesis. Active proliferation of FSC in intralobular fi-brous septa associated with changes in cell morphology (progression from typical FSC to transitional cells to myofibroblasts) and increased collagen synthesis have been observed in animal models of liver fibrosis (9) (10) (11) (12) (13) and in human subjects with alcoholic liver disease (14) .
Chronic tissue inflammation is characterized by the presence of cell types that have the potential to synthesize and secrete cytokines and peptide growth factors. For example, platelet-derived growth factor (PDGF) is released in high concentrations during tissue repair and inflammatory processes, first from platelet alpha granules and subsequently by activated macrophages (15) (16) (17) . Other peptide growth factors that have been shown to be actively released from platelets and activated macrophages, together with PDGF, include epidermal growth factor (EGF), transforming growth factor (TGF)-alpha, TGF-beta, and basic fibroblast growth factor (bFGF; 18). Parenchymal and nonparenchymal liver cells have also been shown to express mRNAs for peptide growth factors (e.g., TGF-alpha and TGF-beta) that seem to regulate hepatocyte growth after partial hepatectomy (19, 20) .
There is very little information about the factors that regulate FSC growth. Preliminary observations suggest that FSC growth may be stimulated by Kupffer cells partly via release of PDGF-like activity (21) . In addition, tumor necrosis factoralpha and IL-1-alpha appear to stimulate, whereas TGF-beta may inhibit, DNA synthesis in FSC (22) . In the present study we explored the effects of PDGF and various polypeptide growth factors on DNA 4 h with 1.0 ,qCi/ml of [3H]TdR (6.7 Ci/mmol; New England Nuclear, Boston, MA) for 4 h. At the end of the pulsing period medium was carefully aspirated, ice-cold 5% TCA was added, and dishes were kept on ice for 15 min. After two additional washes with 5% TCA cells were solubilized by adding 750 ,Ad of0.25 N NaOH, 0.1% SDS. 0.5 ml of the solubilized cell solution was then neutralized with 50 ,l of 6 N HCl and counted in a scintillation counter. Cell number was determined in three separate wells from each dish after trypsinization and counting in a Coulter counter (Coulter Electronics Inc., Hialeah, FL).
Autoradiography
Rat FSC were plated on slides (Lab-Tek) in Waymouth's medium supplemented with serum. Once the cells reached confluency they were made quiescent as described above and then incubated with various growth factors for 20 h followed by a 4-h pulse with [3H]TdR (I qCi/ml). At the end of the pulsing period an equal volume of freshly prepared 3:1 methanol/acetic acid was added to the medium for 10 min. The above half-strength fixative was then replaced by an equal volume of undiluted 3:1 methanol/acetic acid fixative. After 10 min cells were air-dried and exposed to NTB-2 nuclear emulsion (Eastman Kodak Co., Rochester, NY) for 3 d at 40C. The slides were then developed and fixed with D19 developer and fixer (Eastman Kodak Co.), respectively, and stained with Giemsa (25) . 200 cells per each incubation were counted and percent of labeled nuclei (labeling index) was determined.
Cell growth in response to peptide growth factors Rat FSC were plated in 12-well dishes at a density of 4 X 104 cells/well or in 24-well dishes at a density of 2 X 104 cells/well in Waymouth's medium with serum. After 24 h the cells were washed and placed in Waymouth's medium containing 1% Zeta serum for 48 h. This medium was removed and cells were placed in fresh Waymouth's medium with 1% Zeta serum containing the conditions to be tested (time 0). Cell counts were performed on triplicate wells at time 0 and after 3 and 6 d by trypsinizing the cells and using a Coulter counter (Coulter Electronics Inc.). Fresh medium and test conditions were added to the remaining wells at each time point. Results were expressed as percent increment in the presence of the growth factors as compared with cells incubated in medium alone.
Binding ofPDGF to rat FSC Confluent FSC in 24-well dishes at a density of 1.0 X 105 cells/well were made quiescent by placing them in Waymouth's medium supplemented with 1% Zeta serum for 48 h. Cells were then washed twice with binding buffer that consisted of 50% Dulbecco-Vogt modified Eagle's Medium (Gibco Laboratories), 50% Ham's F12 nutrient mixture (Gibco Laboratories), 25 mM Hepes, 2 mg/ml BSA (gammaglobulin free; Sigma Chemical Co.), pH 7.4, and triplicate wells were incubated with increasing concentrations of '25I-PDGF (21,000 cpm/ng) for 2 h at 4°C with constant gentle rotary agitation. At the end of the incubation period the cells were washed three times with ice-cold Dulbecco's PBS containing 1 mM CaCl2 and 2 mg/ml BSA. The monolayer was then solubilized by adding 1.0 ml of 20 mM Hepes, pH 7.4, 1% Triton X-100, 10% glycerol (vol/vol), and 0.1 mg/ml BSA and cells were left at room temperature for 20 min without agitation. The cellbound radioactivity was counted in a gamma counter. Nonspecific binding was determined for two concentrations of '25I-PDGF in each experiment by preincubating triplicate wells with 50-fold excess of purified PDGF for I h at 370C. Specific binding was calculated by subtracting the counts per minute for nonspecific binding from the total counts per minute bound per well. The nonionic detergent Triton X-100 was used to solubilize cell-associated '25I-PDGF without solubilizing dish-bound '25I-PDGF as originally described by Heldin et al. (26) and by Bowen-Pope and Ross (27) . This method circumvents the high nonspecific binding contributed by '251-PDGF that binds to the plastic. Scatchard analysis ofthe binding data was performed using the computer software LIGAND.
Statistical methods
Data, expressed as mean±SD, were analyzed by analysis of variance followed by paired t test.
Results
Results of the immunocytochemical studies performed to characterize and confirm the identity of FSC are summarized in Table I . Strongly positive granular staining for fibronectin and laminin and fibrillar staining for desmin and vimentin were observed in the cytoplasm of FSC in primary (Fig. 1) The kinetics of DNA synthesis in quiescent FSC were studied after stimulation with each of the peptide mitogens ( Fig.  2A) . The addition of PDGF, EGF, TGF-alpha, or bFGF induced a progressive increase in [3H]TdR incorporation into DNA after 12-16 h, reaching a peak effect after 24 h. TGFbeta did not stimulate [3H]TdR incorporation into DNA at any of the time points tested. Fig. 2B shows dose-response curves for the effect of the growth factors. Time-course and dose-response experiments show that PDGF was the most potent inducer of DNA synthesis in quiescent FSC. PDGF stimulated [3H]TdR incorporation into DNA in a dose-dependent manner, with a half-maximal and maximal stimulation at 2 and 10 ng/ml, respectively. EGF, TGF-alpha, and bFGF, although less potent than PDGF, elicited a maximum three-to fourfold increase in DNA synthesis at doses ranging between 10 and 25 ng/ml. Incubation of FSC with increasing doses of TGF-beta did not stimulate [3H]TdR incorporation into DNA. The effects of PDGF and other peptides on DNA synthesis in FSC were confirmed by whole cell autoradiography as shown in Table II . Autoradiographic analysis showed a marked increase ( 18-fold) in labeling index induced by PDGF and, to a lesser extent, by EGF, TGF-alpha, or bFGF. No increase in percent of labeled nuclei was observed when the cells were incubated with TGF-beta alone.
Growth curve experiments for FSC in response to peptide growth factors were performed to demonstrate that the increase in [3H]TdR incorporation into DNA is associated with cell growth. As shown in Fig. 3 , PDGF markedly increased FSC growth after 3 and 6 d of incubation when compared with control. PDGF-induced cell growth was even more evident than the proliferative effect elicited by incubation with complete culture media. Incubation with EGF, TGF-alpha, and bFGF also induced an increase in cell number. The absence of growth stimulation after incubation with TGF-beta further confirmed that TGF-beta by itself is not a mitogen for FSC.
Since PDGF induced the most striking effect on DNA synthesis and cell growth, we attempted to characterize PDGF receptors on FSC. Cultured rat FSC showed significant and highly specific binding of 125I-PDGF as shown in Fig. 4 . In this representative experiment the specific binding of '25I-PDGF ranged between 79 and 84%. Half-maximal binding was at 150-180 pM and saturation was at 550-700 pM (corresponding to 5-6 and 18-23 ng/ml of PDGF, respectively). Scatchard analysis of the '25I-PDGF binding data indicated a single class of receptors with an apparent Kd of 2.3 X 10-' M and an average of 5 X 104 receptor sites per cell. This number of receptors is comparable to that observed in human fibroblasts (26) and human mesangial cells (30) .
Although TGF-beta by itself did not stimulate DNA synthesis in FSC, we studied its effects on EGF or PDGF-induced DNA synthesis. As shown in Fig. 5 , the addition of increasing doses of TGF-beta together with a maximal dose of EGF (Fig.  5A) or PDGF (Fig. 5B) Polypeptide Mitogens and Liver Fat-storing Cells 1789
We'll (32) (33) (34) . The binding studies clearly document the presence of specific receptors for PDGF on FSC. These studies, however, do not clearly identify the receptor subtype(s) present on FSC since the labeled human PDGF, predominantly an AB heterodimer, binds to both types of receptors thus far described (35) . The precise number and distribution of the various types of PDGF receptors present on FSC remains to be determined. The ability of PDGF, bFGF, EGF, and TGF-alpha to stimulate DNA synthesis independently demonstrates that each of these polypeptides functions as a complete growth factor for FSC, unlike the requirement for competence and progression factors which appears to be a unique property for BALB/c 3T3 cells (36) . Although the in vivo biologic relevance of our studies remains speculative, much evidence supports the contention that our in vitro findings may help understand pathogenic mechanisms involved in liver pathology. Macrophage activation is considered a key factor in the pathogenesis of several fibrogenic diseases, including liver cirrhosis (40) , and the release of PDGF from activated macrophages has been proposed to play a major role in the continuing process of fibrogenesis.
Activation of macrophages in vitro induces PDGF release which accounts for -50-70% of the total macrophage-derived mitogenic activity (17) . Therefore the release of PDGF by activated macrophages, including perhaps Kupffer cells, may represent a major stimulus for FSC proliferation and differentiation in conditions of long-standing, self-perpetuating inflammation of the liver lobule, and thus lead to progressive fibrosis. In this context, bFGF, EGF, and TGF-alpha, similarly released by inflammatory cells, including macrophages and platelets, may contribute to the proliferative response of FSC.
These studies demonstrating a potent mitogenic effect of PDGF and other polypeptide growth factors for FSC raise the possibility that they have other biologic effects on these cells. Most of these peptides are known to modulate matrix components as well as enzymes involved in matrix metabolism (32, 41) . Moreover, activated macrophages, a major source ofpolypeptide mitogens in the condition of chronic inflammation, have been shown to elaborate and secrete matrix proteinases capable of degrading basement membrane (42) . In this regard recent studies have clearly demonstrated that changes in the hepatic subendothelial matrix may induce activation of FSC associated with production of type I collagen, which in turn could perpetuate this activated state (43) . Therefore, the eventual role of polypeptide growth factors in inducing FSC proliferation must be seen in a context of complex interactions between soluble factors and perturbation ofthe normal pattern of extracellular matrix.
